Robert Adams to Combined Modality Therapy
This is a "connection" page, showing publications Robert Adams has written about Combined Modality Therapy.
Connection Strength
0.144
-
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016 Feb 13; 387(10019):661-670.
Score: 0.108
-
Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era. Am J Hematol. 2019 12; 94(12):1335-1343.
Score: 0.035